For World Blood Cancer Day this May 28 — a day when advocates around the globe join forces to raise awareness…
Myeloma
The kitchen counter used to mean Sunday mornings. I would stand there slicing up tomatoes, onions, and other vegetables. And as the sharp smell rose,…
A Phase 1 clinical trial testing the experimental therapy KLN-1010 in people with relapsed or refractory multiple myeloma has begun treating patients in the…
I used to say if I needed to take a pill every day to survive, I’d be dead in a week. So it felt like…
Some mornings, I slip into borrowed strength the way other people put on a coat. Others might wonder why I do this. After all, I’m…
Cellcentric has raised $220 million in financing to support two clinical trials testing its potentially first-in-class oral therapy inobrodib in people with hard-to-treat…
My very first journalism teacher, way back in high school, taught me the importance of “who, what, when, where, and why” as building blocks of…
When I wake up some mornings, I check on my mum to see how she’s faring. Then I mentally review two different calendars. One of…
Gilead said it has completed its $7.8 billion acquisition of Arcellx, a deal the company hopes will allow it to streamline and accelerate the…
Note: This column describes the author’s experience with Revlimid (lenalidomide). Not everyone will have the same response to treatment. Consult your doctor before starting or…
Recent Posts
- The caregiver’s invisible ledger tracks what no one else sees
- Study shows protein marker helps predict aggressive myeloma
- New combination therapy cuts risk of death in hard-to-treat myeloma
- Early AML trial finds experimental therapy was generally well tolerated
- Stopping myeloma maintenance therapy at 2 years is safe, study shows
